维普中文期刊产品整合服务
22篇 您的检索式:作者名="GEMA F"
    题名 作者 年代 出处 被引量
1The risk of cardiovascular disease associated with proteinuria in renal transplant patients 显示文摘Gema F F Rafael E Emilio R 2002Transplantation2002,73,8:1
2Postharvest treatment with(-)and(+)methyl jasmonate stimulates anthocyanin accumulation in grapes显示文摘GEMA F GRACIA P B MARIA L R 2015LWT-Food Science and Technology2015,62,1:1
3To adipocyte: a model for integration of endocrine and metabolic signaling, in energy metabolism regulation 显示文摘Gema F Javier G A Francisco J M 2001Am J Physiol Endocrinol Metab2001,280,:1
4To aeipocyte;a model for integration of endocrinl and metabolic signaling in energy metabolism regulation显示文摘Gema F 2001Am J physical Endocrinal Metab2001,280,:1
5To adipocyte :a model for integration of endocrine and metabolic signaling in energy metabolism regulation显示文摘Gema F Javier G A Francisco J M 2001Am J Physiol Endocrinol Metab2001,280,:1
6To adipocyte: a model forintegration of endocrine and metabolic signaling in enery metabolism regulation显示文摘Gema F Javier GA Francisco JM 2002Am J Physiol Endocrinol Metab2002,280,:1
7Human cytomegalovirusimmediate-early mRNA detection by nucleic acid sequence-basedamplification as a new parameter for preemptive therapy in bonemarrow transplant recipients 显示文摘Gema G Baldanti F Lilleri D 2000J Clin Microbiol2000,38,5:1
8To adiposite:a model for integration of endocrine and metabolic signaling in energy metabolism regulation显示文摘Gema F Javier GA Fracisco JM 2001Am J Physiol Endocrinol Metab2001,280,:1
9Phylogenetic patterns of humanrespiratory picomavirus species,including the newly identifiedgroup C rhinoviruses,during a 1 -year surveillance of a hospital-ized patient population in Italy 显示文摘Piralla A Baldanti F Gema G 2011J Clin Microbiol2011,491,:1
10The adipocyte:a model for integration of endocrine and metabolic signaling in energy metabolism regulation显示文摘GEMA F JAVIER G A FRANCISCO J M 2007Am J physiol Endocrinol Metab2007,280,6:1
11Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients显示文摘Gema G Percivalle E Baldanti F 1998New Microbiol1998,21,3:1
12Genetic variability of human coronavirus OC43-, 229E-, and NL63-1ike strains and their association with lower respiratory tract infections of hospital- ized infants and immunocompromised patients 显示文摘Gema G Campanini G Rovida F 2006J Med Virol2006,78,7:1
13Detection of the adulteration of olive oils by solid phase microextraction and multidimensional gas chromatography显示文摘Gema F Maria L R Gracia P B 2006Food Chemistry2006,97,2:1
14What is the optimal level of vitamin D in non-dialysis chronic kidney disease population?显示文摘AIM To evaluate thresholds for serum 25(OH)D concentrations in relation to death, kidney progression and hospitalization in non-dialysis chronic kidney disease(CKD) population.METHODS Four hundred and seventy non-dialysis 3-5 stage CKD patients participating in OSERCE-2 study, a prospective, multicenter, cohort study, were prospectively evaluated and categorized into 3 groups according to 25(OH)D levels at enrollment(less than 20 ng/mL, between 20 and 29 ng/mL, and at or above 30 ng/mL), considering 25(OH)D between 20 and 29 ng/mL as reference group. Association between 25(OH)D levels and death(primary outcome), and time to first hospitalization and renal progression(secondary outcomes) over a 3-year followup, were assessed by Kaplan-Meier survival curves and Cox-proportional hazard models. To identify 25(OH)D levels at highest risk for outcomes, receiver operating characteristic(ROC) curves were performed.RESULTS Over 29 ± 12 mo of follow-up, 46(10%) patients dead, 156(33%) showed kidney progression, and 126(27%) were hospitalized. After multivariate adjustment, 25(OH)D < 20 ng/mL was an independent predictor of all-cause mortality(HR = 2.33; 95%CI: 1.10-4.91; P = 0.027) and kidney progression(HR = 2.46; 95%CI: 1.63-3.71; P < 0.001), whereas the group with 25(OH)D at or above 30 ng/mL did not have a different hazard for outcomes from the reference group. Hospitalization outcomes were predicted by 25(OH) levels(HR = 0.98; 95%CI: 0.96-1.00; P = 0.027) in the unadjusted Cox proportional hazards model, but not after multivariate adjusting. ROC curves identified 25(OH)D levels at highest risk for death, kidney progression, and hospitalization, at 17.4 ng/mL [area under the curve(AUC) = 0.60; 95%CI: 0.685-0.69; P = 0.027], 18.6 ng/mL(AUC = 0.65; 95%CI: 0.60-0.71; P < 0.001), and 19.0 ng/m L(AUC = 0.56; 95%CI: 0.50-0.62; P = 0.048), respectively.CONCLUSION25(OH)D < 20 ng/mL was an independent predictor of death and progression in patients with stage 3-5 CKD, with no additional benefits when patients reached the levels at or above 30 ng/m L suggested as optimal by CKD guidelines.Pablo Molina JoséL Górriz Mariola D Molina Sandra Beltrán Belén Vizcaíno Verónica Escudero Julia Kanter Ana Iávila Jordi Bover Elvira Fernández Javier Nieto Secundino Cigarrán Enrique Gruss Gema Fernández-Juárez Alberto Martínez-Castelao Juan F Navarro-González Ramón Romero Luis M Pallardó 2016World Journal of Nephrology2016,5,5:1
15To adipocyte:a model for in tegration of endocrine and metabolic signaling in enery metabolism regulation显示文摘Gema F J avier G A Francisco J M 2002Am J Physiol Endocrinol Metab2002,,:1
16Protein Kinase C Inhibits CD95(Fas/APO-1)-Mediatd Apoptossis by at Least Two Different Mechanisms in Jurkat T Cells 显示文摘Carmen RR Gema R Jovita F 1999J Immunol1999,163,9:1
17Intracellular signalling pathways activated by leptin 显示文摘Gema F R U 2006Biochem J2006,393,1:1
18Management of human cytomegalovirusinfection in transplant recipients by the pre-emptive therapyapproach 显示文摘Gema G Baldanti F LiUeri D 2009Future Virology2009,4,2:1
19To adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation显示文摘Gema F 2001Am J physical Endocrinal Metab2001,280,:1
20ImmuKnow as a diagnostic tool for predicting infection and acute rejection in adult liver transplant recipients: A systematic review and meta‐analysis显示文摘Emilio Rodrigo Marcos López‐Hoyos Mario Corral Emilio Fábrega Gema Fernández‐Fresnedo David San Segundo Celestino Pi?era Manuel Arias 2012Liver Transpl2012,,10:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费